E1604L, phi29-XT WGA Kit - 100 rxns

E1604L, phi29-XT WGA Kit - 100 rxns

N0433S, Pseudouridine-5’-Triphosphate (Pseudo-UTP) - 10 µmol

N0433S, Pseudouridine-5’-Triphosphate (Pseudo-UTP) - 10 µmol

N0432S, 5-Methyl-Cytidine-5’-Triphosphate (5-Methyl-CTP) - 10 µmol

5.641,02 RON

mRNA has emerged as a potent modality for therapeutics. Incorporation of chemically modified ribonucleotides can improve the utility of mRNA by increasing stability, reducing immunogenicity, and enhancing translatability.

SKU
NEB_N0432S

 

  • Supplied in sodium salt form, pH 7.3.
  • Modified NTPs are commonly used for reduction of immunogenicity for in vitro transcription RNA.
  • No detectable RNase, DNase, phosphatase or protease contaminating activities.
  • ≥95% purity, as determined by HPLC.
  • Optimal activity and stability for up to 24 months. 
  • NTPs are also available as Ribonucleotide Solution Set (NEB #N0450) or Ribonucleotide Solution Mix (NEB #N0466). 

 

Mai multe informatii
Price 4.662,00 RON (preturile sunt fara TVA)
Description

 

  • Supplied in sodium salt form, pH 7.3.
  • Modified NTPs are commonly used for reduction of immunogenicity for in vitro transcription RNA.
  • No detectable RNase, DNase, phosphatase or protease contaminating activities.
  • ≥95% purity, as determined by HPLC.
  • Optimal activity and stability for up to 24 months. 
  • NTPs are also available as Ribonucleotide Solution Set (NEB #N0450) or Ribonucleotide Solution Mix (NEB #N0466).